Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury - PubMed (original) (raw)
. 1989 Dec 1;143(11):3470-5.
Affiliations
- PMID: 2584702
Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury
D C Brennan et al. J Immunol. 1989.
Abstract
TNF and IL-1 are potent immunologic and inflammatory cytokines. We have previously reported increased levels of mRNA for TNF alpha and IL-1 beta in MRL-lpr mice with lupus nephritis. To determine whether the increased levels of TNF and IL-1 mRNA are a more general feature of mice with lupus nephritis we studied cytokine gene expression in female NZB x NZW F1 (NZB/W) mice by Northern blot analysis. Enhanced steady state levels of mRNA for TNF alpha and IL-1 beta, but not IL-1 alpha, were detected in the renal cortices of animals with lupus nephritis. To determine whether administration of TNF or IL-1 would accelerate renal injury and mortality, we injected murine rTNF alpha or rIL-1 alpha i.p. into female NZB/W or C3H/FeJ mice at two doses, 2.0 micrograms or 0.2 micrograms, three times weekly for 2 or 4 mo beginning at 2 or 4 mo of age. Administration of the lower dose of each cytokine accelerated renal disease and mortality rate when treatment was initiated at 4 mo of age. At the higher dose, neither cytokine promoted disease. Treatment administered from 2-4 mo of age did not accelerate renal disease. This observation suggests that in order to cause renal injury, these cytokines must interact with other pathologic features present in these animals after 4 mo of age. These findings support the hypothesis that TNF and IL-1 can contribute to nephritis in murine models of lupus. Taken together with previously published data, we propose that TNF and IL-1 have differential dose effects on renal disease. The dose of TNF and IL-1 and the stage of disease activity dictate the pathogenic action of these cytokines.
Similar articles
- Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis.
Boswell JM, Yui MA, Burt DW, Kelley VE. Boswell JM, et al. J Immunol. 1988 Nov 1;141(9):3050-4. J Immunol. 1988. PMID: 3262676 - Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.
Boswell JM, Yui MA, Endres S, Burt DW, Kelley VE. Boswell JM, et al. J Immunol. 1988 Jul 1;141(1):118-24. J Immunol. 1988. PMID: 3259964 - T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P, Langnickel D, Riemekasten G. Enghard P, et al. Scand J Rheumatol. 2006 May-Jun;35(3):209-16. doi: 10.1080/03009740500417791. Scand J Rheumatol. 2006. PMID: 16766368 - TNF-alpha enhances colony-stimulating factor-1-induced macrophage accumulation in autoimmune renal disease.
Moore KJ, Yeh K, Naito T, Kelley VR. Moore KJ, et al. J Immunol. 1996 Jul 1;157(1):427-32. J Immunol. 1996. PMID: 8683148 - Cytokines expression in SLE nephritis.
Gigante A, Gasperini ML, Afeltra A, Barbano B, Margiotta D, Cianci R, De Francesco I, Amoroso A. Gigante A, et al. Eur Rev Med Pharmacol Sci. 2011 Jan;15(1):15-24. Eur Rev Med Pharmacol Sci. 2011. PMID: 21381496 Review.
Cited by
- Immunomodulatory Activity of Mesenchymal Stem Cells in Lupus Nephritis: Advances and Applications.
Li J, Luo M, Li B, Lou Y, Zhu Y, Bai X, Sun B, Lu X, Luo P. Li J, et al. Front Immunol. 2022 Mar 10;13:843192. doi: 10.3389/fimmu.2022.843192. eCollection 2022. Front Immunol. 2022. PMID: 35359961 Free PMC article. Review. - Dual Role of Interleukin-10 in Murine NZB/W F1 Lupus.
Amend A, Wickli N, Schäfer AL, Sprenger DTL, Manz RA, Voll RE, Chevalier N. Amend A, et al. Int J Mol Sci. 2021 Jan 29;22(3):1347. doi: 10.3390/ijms22031347. Int J Mol Sci. 2021. PMID: 33572870 Free PMC article. - Synergetic Interaction of HLA-DRB1*07 Allele and TNF-Alpha - 863 C/A Single Nucleotide Polymorphism in the Susceptibility to Systemic Lupus Erythematosus.
Katkam SK, Rajasekhar L, Tasneem FSD, Kutala VK. Katkam SK, et al. Indian J Clin Biochem. 2021 Jan;36(1):59-66. doi: 10.1007/s12291-019-00854-9. Epub 2019 Oct 18. Indian J Clin Biochem. 2021. PMID: 33505128 Free PMC article. - Systematic Review: Monoclonal Antibody-Induced Subacute Cutaneous Lupus Erythematosus.
Bolton C, Chen Y, Hawthorne R, Schepel IRM, Harriss E, Hofmann SC, Ellis S, Clarke A, Wace H, Martin B, Smith J. Bolton C, et al. Drugs R D. 2020 Dec;20(4):319-330. doi: 10.1007/s40268-020-00320-5. Drugs R D. 2020. PMID: 32960413 Free PMC article. - Using Multiple Analytical Platforms to Investigate the Androgen Depletion Effects on Fecal Metabolites in a Mouse Model of Systemic Lupus Erythematosus.
Yuan F, Harder J, Ma J, Yin X, Zhang X, Kosiewicz MM. Yuan F, et al. J Proteome Res. 2020 Feb 7;19(2):667-676. doi: 10.1021/acs.jproteome.9b00558. Epub 2019 Dec 27. J Proteome Res. 2020. PMID: 31820642 Free PMC article.